Wei et al. demonstrated that TRIM65 enhances the invasiveness of urothelial carcinoma of the bladder via the ubiquitination and degradation of ANXA2 and modulation of cytoskeleton rearrangement and epithelial–mesenchymal transition (33). Here, TRIM65 is linked to bladder transitional cell carcinoma.